Venture/VC

Rod Cotton plays a vital role in the venture capital ecosystem as a seasoned operator, trusted board advisor, and strategic thought partner to founders navigating the high-stakes early stages of biotech and health tech growth. As a venture partner at 2Flo Ventures — a healthcare and health equity accelerator — Rod works directly with portfolio companies to shape go-to-market strategies, streamline operations, and ensure clinical and commercial alignment. His contributions don’t end at oversight; he’s in the trenches, helping mission-driven startups define their impact while remaining fundable, scalable, and focused.

Rod's value to founders stems from his rare ability to translate complex science into real-world value, earned through decades of executive leadership in diagnostics, pharmaceuticals, and strategic transformation. Having led multi-billion-dollar business units, managed large-scale P&Ls and mergers and acquisitions, Rod understands both the speed and discipline required to build a company that lasts. Startups seek his mentorship not only for his business rigor but for his authenticity — he meets founders with clarity, candor, and a collaborative spirit.

Through his advisory and board roles with early-stage companies like General Genomics, Moleculera Biosciences and 2Flo Ventures, Rod is advancing a new generation of health innovation rooted in equity, precision and access. He believes venture capital is not just about accelerating capital returns, but about accelerating human impact — and his role is to make sure both happen with integrity. Whether in the lab, the boardroom, or the pitch deck, Rod brings the vision and experience to move companies forward with purpose.